Skip to content
ppharmaranks
Menu

Best treatments for legionnaires' disease

4 products may treat legionnaires' disease, spanning FDA drug classes such as rifamycin antibacterial. The current highest-rated option is levofloxacin. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for legionnaires' disease, all are available as lower-cost generics, spanning classes such as rifamycin antibacterial. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for legionnaires' disease — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for legionnaires' disease: 1. Levofloxacin · 2. Rifadin · 3. Rifampin

Top-rated treatments for legionnaires' disease, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$0View →
270/100$21View →
366/100$21View →
4Not yet rated$21View →

Full ranking · 4 treatments

Frequently asked

What treats legionnaires' disease?
Our catalog lists 4 products that may treat legionnaires' disease, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is levofloxacin.
What is the best-rated treatment for legionnaires' disease?
By our independent recall-safety rating — not an efficacy measure — levofloxacin ranks highest among the products we list for legionnaires' disease. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat legionnaires' disease?
Treatments for legionnaires' disease span FDA drug classes including rifamycin antibacterial. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.